Terms: = Gastric cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Staging
5 results:
1. Pan-cancer analysis of prognostic metastatic phenotypes.
Zaorsky NG; Wang X; Garrett SM; Lehrer EJ; Lin C; DeGraff DJ; Spratt DE; Trifiletti DM; Kishan AU; Showalter TN; Park HS; Yang JT; Chinchilli VM; Wang M
Int J Cancer; 2022 Jan; 150(1):132-141. PubMed ID: 34287840
[TBL] [Abstract] [Full Text] [Related]
2. [Correlation analysis of G870A ccnd1 gene polymorphism with digestive system tumors].
Yang SM; Shi YL
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356
[TBL] [Abstract] [Full Text] [Related]
3. [Influencing factors and clinical significance of metastatic lymph node staging in advanced gastric carcinoma].
Zhuo C; Xue Y; Guo Z; Gao W
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jan; 19(1):62-6. PubMed ID: 26797841
[TBL] [Abstract] [Full Text] [Related]
4. Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomes.
Ecker BL; Datta J; McMillan MT; Poe SL; Drebin JA; Fraker DL; Dempsey DT; Karakousis GC; Roses RE
J Surg Oncol; 2015 Nov; 112(6):616-21. PubMed ID: 26394810
[TBL] [Abstract] [Full Text] [Related]
5. Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for gastric cancer.
Yuan R; Wang G; Xu Z; Zhao H; Chen H; Han Y; Wang B; Zhou J; Hu H; Guo Z; Shen H; Xue X
Anticancer Agents Med Chem; 2016; 16(9):1093-100. PubMed ID: 26179261
[TBL] [Abstract] [Full Text] [Related]
